New Lecture on Video-Oculography-Based Biomarkers for neurological disorders

At the EAN Congress 2026 in Geneva, Bulbitech Chief Medical Officer and neurologist Ivania Patry, MD, presented a lecture on video-oculography-based biomarkers for neurological disorders, including Parkinson's disease, Ataxia, and Multiple Sclerosis.

The presentation demonstrated how oculometrics, captured through video-oculography, can be translated into meaningful functional biomarkers.

Looking ahead, Bulbitech is also exploring a risk score (work in progress) to translate eye-movement data into a more useful clinical test result.

Next
Next

New Study Highlights BulbiCAM’s Potential in Parkinson’s Disease Monitoring